Review outlines next-generation precision approaches for microsatellite-stable tumors, including antibody-drug conjugates, bispecific antibodies, DNA damage response targeting, and tumor microenvironment-directed therapies. (ESMO Open)
Precision oncology strategies beyond RAS and RAF in MSS colorectal cancer
The CRC Digest